Want to see HK:3309 full AI Analyst Report?
Top Page
C-MER Eye Care Holdings Limited
(3309)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$0.87
▼(-48.65% Downside)
Action:Reiterated
Date:08/06/26
The score is supported primarily by strong cash flow and a solid, moderately levered balance sheet, alongside reasonable valuation. These positives are meaningfully tempered by weak technical trends and momentum, plus a history of profit volatility that increases uncertainty.
Positive Factors
Strong cash generation
Recurring positive operating cash flow and strong free cash flow provide internal funding for clinical expansion, facility investment, and shareholder returns. The 2025 improvement in free cash flow also indicates better cash conversion, strengthening financial resilience over the next several quarters.
Negative Factors
Earnings volatility
Repeated swings between losses and profits make future earnings power less predictable and weaken confidence in consistent returns on the company’s medical network. This volatility can constrain reinvestment planning and makes operating performance more dependent on execution in each reporting period.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Recurring positive operating cash flow and strong free cash flow provide internal funding for clinical expansion, facility investment, and shareholder returns. The 2025 improvement in free cash flow also indicates better cash conversion, strengthening financial resilience over the next several quarters.
Read all positive factors
C-MER Eye Care Holdings Limited (3309) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.05B
Dividend Yield2.29%
Average Volume (3M)510.63K
Price to Earnings (P/E)10.1
Beta (1Y)0.82
Revenue Growth4.75%
EPS GrowthN/A
CountryHK
Employees2,200
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.08
Shares Outstanding1,232,342,900
10 Day Avg. Volume431,812
30 Day Avg. Volume510,632
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.17
Price to Sales (P/S)1.07
P/FCF Ratio9.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)N/A
C-MER Eye Care Holdings Limited Business Overview & Revenue Model
Company Description
C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and th...
How the Company Makes Money
C-MER primarily makes money by charging patients (and, where applicable, third-party payors) for clinical eye-care services delivered through its own medical network. Key revenue streams typically include: (1) outpatient services such as specialis...
C-MER Eye Care Holdings Limited Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
78
Positive
Cash Flow
84
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.03B | 1.95B | 1.91B | 1.92B | 1.73B | 1.11B |
| Gross Profit | 633.13M | 603.67M | 527.62M | 618.96M | 365.34M | 309.44M |
| EBITDA | 373.27M | 341.37M | 343.30M | 363.38M | 194.31M | 177.80M |
| Net Income | 100.44M | 100.37M | -135.16M | 62.00M | -21.88M | 21.86M |
Balance Sheet | ||||||
| Total Assets | 2.86B | 2.73B | 2.72B | 2.75B | 2.90B | 1.96B |
| Cash, Cash Equivalents and Short-Term Investments | 563.37M | 465.96M | 467.25M | 557.42M | 698.51M | 442.36M |
| Total Debt | 433.61M | 426.78M | 437.79M | 362.99M | 452.49M | 471.69M |
| Total Liabilities | 868.58M | 796.01M | 830.24M | 755.35M | 903.45M | 618.63M |
| Stockholders Equity | 1.83B | 1.77B | 1.75B | 1.85B | 1.87B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | 323.23M | 223.94M | 124.50M | 245.30M | 100.63M | 19.18M |
| Operating Cash Flow | 400.23M | 301.47M | 283.12M | 361.15M | 191.86M | 148.41M |
| Investing Cash Flow | -45.70M | -169.66M | -174.72M | -245.37M | -210.65M | -392.72M |
| Financing Cash Flow | -196.81M | -212.38M | -194.92M | -242.88M | 293.68M | 85.12M |
C-MER Eye Care Holdings Limited Technical Analysis
Neutral
1.70
Price Trends
0.82
Positive
0.88
Negative
1.10
Negative
Market Momentum
0.01
Negative
56.19
Neutral
80.77
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3309, the sentiment is Neutral. The current price of 1.7 is above the 20-day moving average (MA) of 0.81, above the 50-day MA of 0.82, and above the 200-day MA of 1.10, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 56.19 is Neutral, neither overbought nor oversold. The STOCH value of 80.77 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:3309.
C-MER Eye Care Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.66B | 8.34 | 6.97% | 10.27% | 3.85% | -1.23% | |
71 Outperform | HK$581.85M | 5.27 | 6.35% | 10.92% | -0.27% | 29.73% | |
68 Neutral | HK$1.47B | 4.16 | 17.86% | 2.16% | 1.25% | 12.60% | |
67 Neutral | HK$1.05B | 10.10 | 5.57% | 2.29% | 4.75% | ― | |
66 Neutral | HK$703.50M | 285.71 | 0.20% | 2.00% | 20.54% | -96.74% | |
52 Neutral | HK$1.10B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:3309
C-MER Eye Care Holdings Limited
0.85
-0.91
-51.81%
HK:1526
Rici Healthcare Holdings Ltd.
0.93
-0.07
-7.22%
HK:1846
EuroEyes International Eye Clinic Limited
2.20
-1.09
-33.17%
HK:2219
Chaoju Eye Care Holdings Ltd.
2.36
<0.01
0.43%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.74
-0.03
-1.97%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.11
-40.07%
C-MER Eye Care Holdings Limited Corporate Events
C-MER Medical Posts Higher Revenue but Softer Adjusted Profit in First Half of 2026
Aug 25, 2026
C-MER Medical Holdings Limited reported unaudited interim results for the six months ended 30 June 2026, showing revenue of HK$1,024.4 million, up 8.5% year on year. Gross profit rose 10.0% to HK$323.4 million and gross margin improved slightly to...
C-MER Completes Strategic Investment in CHIGENOVO and Secures Exclusive Rights to ZVS101e
Aug 10, 2026
C-MER Medical Holdings Limited has completed its previously announced investment transactions in CHIGENOVO Co., Ltd., a move that secures a strategic minority stake in the medical company. Through its subsidiary HK (International) Eye Care, C-MER ...
C-MER Medical Sets August Board Meeting to Approve Interim Results and Consider Dividend
Aug 7, 2026
C-MER Medical Holdings Limited has scheduled a board meeting for 25 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider whether to recommend an interim dividend and handle other...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.